iShares Biotechnology ETF

IBB
$168.11 $-1.26 (-0.75%)
Market Cap: $8.45 B
Gurus Holding
5
Popularity Rank
#1628
% of Shares Held
0.96%
Net Activity (Q3 2025)
+$69.94 M

Guru Ownership Trend

Guru Analysis for iShares Biotechnology ETF (IBB)

iShares Biotechnology ETF (IBB), a key player in the Market sector, continues to attract institutional attention.

As of Q3 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $82.73 M.

Top institutional holders include Jefferies Group and Renaissance Technologies.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $69.94 M net inflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Cliff Asness reduced exposure by 3.8%.

Portfolio Manager % Portfolio Activity Shares Value Period
0.31% New Buy 450,807 $65.08 M Q3 2025
0.01% New Buy 27,482 $3.97 M Q3 2025
0.00% New Buy 6,450 $931,187 Q3 2025
0.00% Reduce -3.8% 5,162 $745,238 Q3 2025
0.00% Reduce -3.0% 2,200 $317,614 Q3 2025

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2025)

+$69.98 M
Total Buy Value
New Buys 3
Additions 0
-$38,691.16
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q3 2025)

Based on recent activity
Net Sellers
2
Net Buyers
3

FAQs for iShares Biotechnology ETF (IBB)

Top Guru holders include Jefferies Group ($65.08 M), Renaissance Technologies ($3.97 M), Paul Tudor Jones ($931,187). Collectively, tracked Gurus hold 492,101 shares.

Based on recent 13F filings, the sentiment is Positive (Net Buy). There was a net inflow of $69.94 M, with 3 Gurus buying and 2 Gurus selling.

In the recent quarter, 2 Gurus reduced their positions, and 0 Gurus sold out of IBB completely. Total sell value was $38,691.16.

Yes, 3 Gurus opened new positions in IBB, and 0 added to their existing holdings. Total buy value was $69.98 M.